Ardelyx | ARDX - Gross Profit On Sales

Stock Price
6.10
Daily Change
-0.01 -0.16%
Monthly
-3.17%
Yearly
50.25%
Q2 Forecast
6.10

Ardelyx reported $114.37M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Amgen USD 6.89B 415M Dec/2025
Ardelyx USD 114.37M 8.02M Dec/2025
aTyr Pharma USD 190K 15.57M Sep/2025
Corcept Therapeutics USD 162.02M 37.56M Mar/2026
Curis USD 1.14M 8.86M Dec/2025
Sanofi EUR 8.45B 3.02B Dec/2025
TG Therapeutics USD 171.41M 16.98M Mar/2026
United Therapeutics USD 315.5M 286.6M Dec/2025
Xoma 992K 846K Jun/2024